Supplementary Table 1-5 from Allogeneic B7-H3–Targeted CAR Vδ1T-cell Therapy in Advanced Solid Tumors: A Phase I Study

作者：Chang Liu, Jiarui Li, Dan Liu, Panpan Zhang, Miao Zhang, Ran Xue, Jifang Gong, Lian Liu, Min Tao, Siyuan Cheng, Ting Xu, Jiajia Yuan, Yanshuo Cao, Z. Wang, Yakun Wang, Jun Zhou, Ming Lu, Zhi Peng, Zhihao Lü, Jian Li, Xiaotian Zhang, Tian Wang, Min Wang, Licui Jiang, Huimin Meng, Lin Yang, Changsong Qi, Lin Shen · 年份：2026 · DOI：10.1158/1078-0432.32709647 · 研究领域：CAR-T cell therapy research、Phagocytosis and Immune Regulation、Biomedical Ethics and Regulation

<p>Supplementary Table 1 Final Product Release Criteria for UTAA06 Supplementary Table 2 Representativeness of Study Participants Supplementary Table 3 Baseline Characteristics and Clinical Outcomes of Individual Patients Supplementary Table 4 Characteristics of UTAA06 Products Supplementary Table 5 Serum Tumor Marker Kinetics</p>